A detailed history of Mercer Global Advisors Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 10,000 shares of CDXC stock, worth $56,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Holding current value
$56,400
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$3.25 - $7.72 $32,500 - $77,200
10,000 New
10,000 $53,000
Q1 2024

May 15, 2024

BUY
$1.36 - $3.84 $13,600 - $38,400
10,000 New
10,000 $35,000
Q3 2023

Nov 13, 2023

BUY
$1.36 - $1.77 $13,600 - $17,700
10,000 New
10,000 $15,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $385M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.